LITTELFUSE INC /DE financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data LITTELFUSE INC /DE files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,056	1,222	1,718	1,504	1,446	2,080	2,514	2,363	2,191	2,386
Cost of revenue	643	715	1,065	958	945	1,308	1,507	1,462	1,403	1,480
Gross profit	413	507	653	546	501	772	1,007	900	788	906
Research and development	42.2	50.5	87.3	80	52.5	65.9	95.6	102	108	107
Selling, general and administrative	206	213	276	220	205	275	345	355	350	382
Operating expenses	282	288	428	354	339	386	506	539	629	869
Operating income	131	219	225	193	162	386	501	361	159	37.5
Interest expense	8.63	13.4	22.6	22.3	21.1	18.5	26.2	39.9	38.7	34.3
Other non-operating income	1.73	1.28	1.6	0.58	5.08	-8.93	-7.21	19.9	22.6	17
Pre-tax income	123	204	205	166	161	341	443	329	152	3.61
Income tax	18.8	84.5	40.4	26.8	31.3	57.2	69.7	69.1	51.7	75.3
Net income	104	120	165	139	130	284	373	259	100	-71.7
EBITDA	184	282	328	285	259	484	622	498	227	112
EPS, basic	4.63	5.27	6.62	5.66	5.33	11.54	15.09	10.44	4.04	-2.89
EPS, diluted	4.60	5.21	6.52	5.60	5.29	11.38	14.94	10.34	4.00	-2.89
Shares, basic (weighted)	22.6	22.7	24.9	24.6	24.4	24.6	24.7	24.9	24.8	24.8
Shares, diluted (weighted)	22.7	22.9	25.2	24.8	24.6	24.9	25	25.1	25	24.8
Dividend per share			1.60	1.82	1.92	2.02	2.26	2.50	2.70	2.90

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	275	430	490	531	688	478	563	556	725	563
Short-term investments	3.69	0.04	0.03	0.04	0.05	0.03	0.08	0.24	0.98	0.29
Receivables	176	183	233	202	233	275	307	287	294	363
Inventory	114	141	258	238	258	446	548	475	416	416
Other current assets	31.5	37.5	49.3	28.6	35.9	68.8	87.6	82.5	104	85.8
Total current assets	612	792	1,033	1,004	1,217	1,270	1,512	1,409	1,552	1,435
Property, plant and equipment	217	251	340	345	344	438	481	493	477	541
Lease right-of-use assets			0	21.9	17.6	29.6	54.9	61	71.5	86.3
Goodwill	404	453	827	821	817	930	1,187	1,310	1,229	1,211
Intangible assets	213	204	361	321	292	407	594	606	482	595
Long-term investments	13.9	11	25.4	24.1	30.5	39.2	24.1	24.8	23.2	20
Other non-current assets	10.8	17.1	21	15	18	24.7	34.1	79.7	51.7	63
Total assets	1,491	1,740	2,614	2,560	2,748	3,152	3,904	3,995	3,892	3,957
Accounts payable	90.7	102	126	117	146	222	209	174	188	211
Accrued liabilities	36.1	100	138	84.1	110	160	187	149	148	199
Deferred revenue					3.86
Short-term debt	6.25	6.25	10	10	0	25	135	14	67.6	96.2
Total current liabilities	188	225	295	226	276	435	572	375	434	533
Long-term debt	448	489	685	669	687	612	867	858	789	706
Lease liabilities			0	17.2	13	22.3	45	49.2	60.6	71.8
Other non-current liabilities	20.4	62.6	72.2	64	67.3	71	79.5	86.7	69.8	78.8
Total liabilities	676	813	1,136	1,064	1,139	1,258	1,692	1,515	1,478	1,531
Total debt	454	496	695	679	687	637	1,001	872	856	803
Paid-in capital	291	310	836	868	908	947	974	1,012	1,049	1,098
Retained earnings	634	722	857	951	1,034	1,268	1,585	1,783	1,816	1,672
Treasury stock	-36.5	-41.3	-116	-216	-242	-248	-253	-259	-305	-339
Other comprehensive income	-74.6	-63.7	-97.9	-107	-91.2	-73.5	-95.8	-55.8	-146	-5.38
Shareholders' equity	815	927	1,478	1,496	1,609	1,893	2,211	2,480	2,413	2,426
Minority interests	0.14	0.14	0.13	0.13	0.13	0.13	0.18	0.31	0.36	0
Total equity	815	928	1,478	1,496	1,609	1,894	2,211	2,480	2,414	2,426
Total liabilities and equity	1,491	1,740	2,614	2,560	2,748	3,152	3,904	3,995	3,892	3,957
Shares outstanding	22.6	22.7

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	104	120	165	139	130	284	373	259	100	-71.7
Depreciation and amortization	53.1	63	103	92.5	96.2	98.6	121	137	68.3	74.9
Stock-based compensation	12	16.3	27.4	19	18.1	19.6	23.6	23.9	26	27.3
Deferred income tax	-5.27	17.1	-4.68	-1.15	-3.21	-8.02	-22.4	0.05	-2.82	3.34
Change in receivables	-22.8	-11.1	-3.54	28.5	-25.6	-10.2	-19.3	24.5	-15.3	-36.4
Change in inventory	8.54	-20.2	-34	22.1	-12.4	-105	-89.2	82.5	47.1	40.2
Change in payables	19.2	6.49	13.7	-22.6	28.8	40.5	-22.4	-36.3	16.3	11.3
Cash from operations	180	269	332	245	258	373	420	457	368	434
Capital expenditures	-46.2	-65.9	-74.8	-61.9	-56.2	-90.6	-104	-86.2	-75.9	-67.6
Acquisitions	-471	-38.5	-318	-0.78	0	-424	-533	-199	0	-408
Cash from investing	-511	-96.1	-382	-56.5	-51.4	-499	-636	-284	-65.8	-469
Stock issued	20.5
Share buybacks	0	0	-63.6	-99.4	-22.9	0	0	0	-40.9	-27.6
Dividends paid	-27.9	-31.8	-40	-44.7	-46.8	-49.7	-55.9	-62.2	-67.1	-72
Cash from financing	284	-24.7	122	-146	-67.8	-69	310	-186	-112	-149
Exchange rate effect	-6.75	6.2	-11.4	-1.19	17.6	-9.89	-11.4	4.84	-20.1	23
Net change in cash	-53.7	155	60.1	41.4	156	-205	82.1	-7.82	169	-161
Free cash flow	134	203	257	183	202	283	315	371	292	366
Interest paid	8.6	10.6	18.5	21.2	20.1	17.4	25.4	37.2	36.2	34.4
Income taxes paid	35.6	18.1	41.9	40.5	27.6	55.6	93.6	73.9	83.8	81.6

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to March 28, 2026; growth uses fiscal years. Valuation uses the share price of $429.22 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	38.3%	Gross profit / revenue.
Operating margin	2.8%	Operating income / revenue.
EBITDA margin	46.1%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	1.6%	Pre-tax income / revenue.
Net margin	-1.6%	Net income / revenue.
FCF margin	15.7%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	18.0%	Cash from operations / revenue.
Effective tax rate	199.3%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	-1.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-1.0%	Net income / average total assets.
Return on invested capital (ROIC)	2.0%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	4.4%	Research and development expense / revenue.
SG&A / revenue	15.8%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.1%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.4%	Capital expenditures / revenue.
D&A / revenue	43.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	8.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-1.7%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	10.5%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	15.0%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-3.5%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	12.6%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-76.4%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-57.8%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-25.4%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-50.5%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-43.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-15.3%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-171.6%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-172.3%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	18.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	1.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	10.9%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	25.5%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	5.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	12.6%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	7.4%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	8.7%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	8.6%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	0.5%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	3.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	8.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	1.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	0.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	7.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.9%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.61x	Current assets / current liabilities.
Quick ratio	1.64x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.91x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.25x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	16.4%	Total debt / total assets.
Liabilities / assets	34.8%	Total liabilities / total assets.
Net debt	$149.6M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	0.13x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	2.12x	Operating income / interest expense.
Working capital	$848.9M	Current assets - current liabilities.
Goodwill and intangibles / assets	46.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	$734.2M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.65x	Revenue / average total assets.
Fixed asset turnover	4.67x	Revenue / average property, plant and equipment.
Inventory turnover	3.67x	Cost of revenue / average inventory.
Days inventory	100 days	365 x average inventory / cost of revenue.
Receivables turnover	6.53x	Revenue / average receivables.
Days sales outstanding	56 days	365 x average receivables / revenue.
Days payables	53 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	103 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	13.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$1.58	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$97.91	Revenue / diluted weighted shares.
FCF per share	$15.33	Free cash flow / diluted weighted shares.
Operating cash flow per share	$17.63	Cash from operations / diluted weighted shares.
Book value per share	$98.90	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$28.88	Tangible book value / shares outstanding.
Cash per share	$18.96	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	0.0%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$10.90B	Share price x shares outstanding.
Enterprise value	$11.05B	Market cap + total debt - cash - short-term investments.
P/S	4.38x	Market cap / revenue.
P/B	4.34x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	14.8x	Market cap / tangible book value, when positive.
P/FCF	28.0x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	24.3x	Market cap / cash from operations, when positive.
EV/Sales	4.44x	Enterprise value / revenue.
EV/EBIT	161x	Enterprise value / operating income, when both are positive.
EV/EBITDA	9.64x	Enterprise value / EBITDA, when both are positive.
EV/FCF	28.4x	Enterprise value / free cash flow, when both are positive.
FCF yield	3.6%	Free cash flow / market cap.
Earnings yield	-0.4%	Net income / market cap (the inverse of P/E).
Shareholder yield	0.0%	(Dividends paid + share buybacks) / market cap.

What was LITTELFUSE INC /DE's revenue in fiscal 2025?

LITTELFUSE INC /DE reported revenue of $2.39B for fiscal 2025, 8.9% higher than the year before.

Was LITTELFUSE INC /DE profitable in fiscal 2025?

No. It reported a net loss of $71.7M.

How much free cash flow did LITTELFUSE INC /DE generate in fiscal 2025?

Cash from operations of $433.8M minus capital expenditures of $67.6M left free cash flow of $366.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to LITTELFUSE INC /DE